Natural History of Autosomal Dominant Hearing Loss
A legfontosabb adatok
- Ki végzi
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Hol
- Bethesda (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 1100 fő, tervezett
- Kezdés
- 2021. febr. 9.
- Várható befejezés
- 2029. aug. 21.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A regiszteradat frissítve
- 2026. november 6.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for people with hearing loss that runs in families and is passed on in a dominant way (DFNA). Their family members, with or without hearing loss, can also join.
- Életkor
- 3 to 99 years
- Nem
- All sexes
- A betegség stádiuma
- Hereditary sensorineural hearing loss (inner ear or nerve hearing loss) passed on in an autosomal dominant way. Unaffected family members of enrolled participants can also join.
- Biomarker vagy leletérték
- Hearing loss preferably confirmed by earlier genetic testing.
A részvétel fő kizáró okai
- Hearing loss or balance problems from a non-genetic cause, such as infection, metabolic or immune disorders
- Hearing loss after drugs that can harm hearing, such as cisplatin or aminoglycoside antibiotics
- Hearing loss linked to surgery, such as acoustic neuroma removal or failed stapedectomy
- Thinking problems that leave a person unable to give consent
A regiszter feltételei, szó szerint
Mind a 9 feltétel megnézéseKevesebb
Ki nem vehet részt
- Persons with sensorineural hearing loss known to be associated with surgical intervention (e.g. acoustic neuroma removal, failed stapedectomy); Prospective study subjects who are cognitively impaired and lack consent capacity, will not be enrolled. The pre-screening eligibility checklist, which will be used and documented for registration under this protocol, is provided in a separate document
- Persons with sensorineural hearing loss (SNHL) and/or peripheral vestibular dysfunction associated with a non-genetic etiology such as infection, metabolic or immunologic disorders, or exposure to ototoxic agents such as cisplatin, or aminoglycoside antibiotics will not be included in this protocol
Egyéb feltételek
- INCLUSION CRITERIA:
- Affected persons with autosomal dominant hereditary sensorineural hearing loss, preferably confirmed by prior genetic testing
- Affected family members of enrolled participants with known autosomal dominant hereditary hearing loss
- Unaffected Family Members (Healthy Volunteers) of enrolled participant
- Adults must be able to provide informed consent
- Minors must have a parent or guardian able to provide informed consent
- Subjects must be 3-99 years of age
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 3 és 99 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- National Institutes of Health Clinical CenterBethesda, Egyesült ÁllamokContact: Maame S AkumateyRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Background:
A teljes eredeti leírásKevesebb
Hereditary hearing loss is one of the most common sensory disabilities affecting newborns. The main options for people with hereditary hearing loss are hearing aids and cochlear implants. Both options have their limitations and do not restore biological hearing. Researchers want to learn if gene editing might be a treatment option.
Objective:
To understand the genes that cause non-syndromic autosomal dominant hearing loss (DFNA) in people with DFNA as well as their family members.
Eligibility:
People age 3 99 who have DFNA, affected family members of enrolled participants with DFNA, and unaffected family members of enrolled participants
Design:
Participants will be screened with a medical and hearing history. Their medical records will be reviewed.
Participants will have hearing tests. They will wear headphones or earplugs. They will listen to tones, sounds, and words and may be asked to describe what they hear.
Participants will have balance tests. For these, they will wear googles as they watch moving lights or as cold or warm air is blown into their ears. They will sit in a spinning chair in a quiet, dark booth. From a reclined position, they will raise their head while listening to clicking sounds.
Participants will have blood drawn through a needle in the arm. Some blood will be used for gene testing.
Some participants will have 2 skin biopsies. The skin will be washed, and a numbing medicine will be injected. Two small pieces of skin will be removed.
Participants may have a physical exam.
Participation will last for up to 20 years. Participants may give medical updates once a year.
A vizsgálat 2 csoportja
- 1
DFNA patients and their family members (affected)
- 2
DFNA patients and their family members (unaffected)
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT04501081: ki vehet részt
- A regiszteradat frissítve
- 2026. november 6.